サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494496

欧州の血管閉鎖装置：2030年市場予測- 地域別分析- 製品タイプ、アクセス、手技、エンドユーザー別

Europe Vascular Closure Device Market Forecast to 2030 - Regional Analysis - by Product Type, Access, Procedure, and End User

出版日
ページ情報
英文 97 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
欧州の血管閉鎖装置：2030年市場予測- 地域別分析- 製品タイプ、アクセス、手技、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 97 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の血管閉鎖装置市場は、2022年に3億6,263万米ドルと評価され、2030年には6億2,174万米ドルに達すると予測され、2022年から2030年までのCAGRは7.0%を記録すると予測されています。

メーカーによる戦略的活動が欧州の血管閉鎖装置市場を牽引

医療機器業界は、技術的に先進的な製品に対する需要の高まりにより、著しく発展しています。主要市場企業は、効率的な製品の革新と開発を確実にするため、新製品の開発、上市、承認に取り組んでいます。血管閉鎖装置市場における最近の製品発売と承認の一部を以下に紹介します。

2022年9月、Haemonetics CorporationはVASCADEおよびVASCADE MVP静脈血管閉鎖システムのCEマーク認証を取得しました。CEマーキングの取得により、Haemonetics社は両製品を欧州連合（EU）に投入する次のステップに取り組むことができます。2021年現在、バスケードMVPは、心房細動（AF）アブレーション後に使用され、同日退院が可能な血管閉鎖装置として、FDAに承認された最初で唯一の製品です。

2023年9月、テルモ・メディカル・コーポレーションのクロスシール縫合血管閉鎖装置システムがFDAから承認を受けた。この装置は、8Fから18Fのシースを用いて診断的またはインターベンショナルなカテーテル治療を受けた患者において、止血までの時間を短縮しながら総大腿動脈アクセス部位を閉鎖するための縫合糸を経皮的に送達することを適応とします。クロスシールシステムは、片脚1カ所のアクセス部位に適応されます。このような戦略的イニシアチブは、予測期間中、欧州の血管閉鎖装置市場の主要動向として浮上する可能性が高いです。

欧州の血管閉鎖装置市場概要

心血管系疾患はドイツで最も一般的な死因のひとつです。大衆のライフスタイルの変化がこの疾患の主な危険因子です。心血管系疾患はドイツにおける死因の40％を占め、次いでがんと糖尿病です。WHOによると、2020年のドイツにおける冠動脈性心疾患による死亡者数は147,055人（すなわち死亡者全体の20.98％）に達します。発達したヘルスケア施設の存在や、低侵襲の心臓病手術の増加は、血管閉鎖装置の需要を生み出す要因のひとつです。キングス・カレッジ・ロンドンが欧州脳卒中連合（Stroke Alliance for Europe）のために作成した報告書「Burden of Stroke in Europe」に掲載されたデータによると、ドイツでは年間88,922例の脳卒中が発生しており、これは人口10万人当たり52例近くに相当します。ドイツにおける脳卒中の有病率は526,774人で、人口10万人当たり338.5人です。また、年間75,861人が脳卒中により死亡しており、脳卒中による死亡率も高いです。欧州における脳卒中の負担に関する報告書によると、ドイツにおける脳卒中患者は2035年までに30％急増し、脳卒中の有病率は2035年末までに19％まで上昇すると予測されています。このように、脳卒中と心血管障害の発生率が著しく増加していることが、ドイツの血管閉鎖装置市場の成長を牽引しています。

欧州の血管閉鎖装置市場の収益と2030年までの予測（金額）

欧州の血管閉鎖装置市場のセグメンテーション

欧州の血管閉鎖装置市場は、製品タイプ、アクセス、手技、エンドユーザー、国別に区分されます。

製品タイプ別では、欧州の血管閉鎖装置市場は、アクティブ、パッシブ、外部止血デバイスに区分されます。パッシブセグメントが2022年に最大のシェアを占めました。能動的近似器セグメントはさらに縫合糸介在デバイスとステープルクリップ介在デバイスにセグメント化されます。受動的近似器セグメントはさらに、シーラントとゲルベース、圧迫デバイス、コラーゲンプラグにセグメント化されます。

アクセス別では、欧州の血管閉鎖装置市場は大腿骨アクセスと橈骨アクセスに二分されます。2022年には、大腿骨アクセスセグメントがより大きなシェアを占めています。

手技別では、欧州の血管閉鎖装置市場はインターベンショナルカーディオロジー、インターベンショナルラジオロジー、血管内手術に区分されます。インターベンショナルカーディオロジーアクセスセグメントが2022年に最も大きなシェアを占めました。

エンドユーザー別では、欧州の血管閉鎖装置市場は病院、外来手術センター、その他に分類されます。病院セグメントが2022年に最大のシェアを占めました。

国別では、欧州の血管閉鎖装置市場はドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。その他欧州が2022年の欧州の血管閉鎖装置市場を独占しました。

Abbott Laboratories、Becton Dickinson and Co、Cardinal Health Inc、Cordis Corp、ENDOCOR GmbH &CO KG、Haemonetics Corp、Medtronic Plc、Teleflex Inc、Vasorum Ltdは、欧州の血管閉鎖装置市場で事業展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の血管閉鎖装置市場- 主要産業力学

  • 市場促進要因
    • 心血管疾患の有病率の増加
    • 低侵襲デバイスに対する需要の急増
  • 市場抑制要因
    • 血管閉鎖装置に関する感染リスク
  • 市場機会
    • 新興経済圏の未開拓の可能性
  • 今後の動向
    • メーカーによる戦略的活動
  • 影響分析

第5章 血管閉鎖装置市場：欧州市場分析

  • 欧州の血管閉鎖装置市場売上高、2022年～2030年

第6章 欧州の血管閉鎖装置市場：製品タイプ別

  • アクティブ
  • パッシブ
  • 外部止血デバイス

第7章 欧州の血管閉鎖装置市場：アクセス別

  • 大腿骨アクセス
  • ラジアルアクセス

第8章 欧州の血管閉鎖装置市場：手技別

  • インターベンショナル・カーディオロジー
  • インターベンショナル放射線学
  • 血管内外科

第9章 欧州の血管閉鎖装置市場：エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第10章 欧州の血管閉鎖装置市場：国別

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第11章 血管閉鎖装置市場の業界情勢

  • 血管閉鎖装置市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Cordis Corp
  • Vasorum Ltd
  • Haemonetics Corp
  • Abbott Laboratories
  • Becton Dickinson and Co
  • Cardinal Health Inc
  • ENDOCOR GmbH & CO KG
  • Medtronic Plc
  • Teleflex Inc

第13章 付録

図表

List Of Tables

  • Table 1. Europe Vascular Closure Device Market Segmentation
  • Table 2. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 3. Germany: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany: Europe Vascular Closure Device Market, by Passive Approximators - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Access
  • Table 6. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Procedure
  • Table 7. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - End Users
  • Table 8. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 9. UK: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
  • Table 10. UK: Europe Vascular Closure Device Market, by Passive Approximators - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Access
  • Table 12. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Procedure
  • Table 13. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - End Users
  • Table 14. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 15. France: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France: Europe Vascular Closure Device Market, by Passive Approximators - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Access
  • Table 18. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Procedure
  • Table 19. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - End Users
  • Table 20. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 21. Italy: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy: Europe Vascular Closure Device Market, by Passive Approximators - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Access
  • Table 24. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Procedure
  • Table 25. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - End Users
  • Table 26. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 27. Spain: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Spain: Europe Vascular Closure Device Market, by Passive Approximators - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Access
  • Table 30. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Procedure
  • Table 31. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - End Users
  • Table 32. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 33. Rest of Europe: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe: Europe Vascular Closure Device Market, by Passive Approximators - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Access
  • Table 36. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - Procedure
  • Table 37. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) - End Users
  • Table 38. Recent Inorganic Growth Strategies in the Vascular Closure Devices Market
  • Table 39. Recent Organic Growth Strategies in the Vascular Closure Devices Market
  • Table 40. Glossary of Terms, Europe Vascular Closure Device Market

List Of Figures

  • Figure 1. Europe Vascular Closure Device Market Segmentation, By Country
  • Figure 2. Europe Vascular Closure Device Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Vascular Closure Device Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Europe Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
  • Figure 6. Active Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Passive Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. External hemostatic devices: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
  • Figure 10. Femoral Access: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Radial Access: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Europe Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
  • Figure 13. Interventional Cardiology: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Ceramic: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Endovascular Surgical: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
  • Figure 17. Hospitals: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Ambulatory Surgical Center: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Vascular Closure Device Market, By key Country - Revenue (2022) (US$ Million)
  • Figure 21. Europe Vascular Closure Device Market, By Key Countries, 2022 And 2030 (%)
  • Figure 22. Germany: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 23. UK: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 24. France: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 25. Italy: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 26. Spain: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 27. Rest of Europe: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 28. Growth Strategies in the Vascular Closure Devices Market
目次
Product Code: BMIRE00029950

The Europe vascular closure device market was valued at US$ 362.63 million in 2022 and is expected to reach US$ 621.74 million by 2030; it is estimated to record a CAGR of 7.0% from 2022 to 2030.

Strategic Activities by Manufacturers Drive Europe Vascular Closure Device Market

The medical device industry is developing significantly due to the increasing demand for technologically advanced products. Major market players engage in new product developments, launches, and approvals to ensure the innovation and development of efficient products. A few of the recent product launches and approvals in the vascular closure devices market are mentioned below.

In September 2022, Haemonetics Corporation obtained CE mark certification for its VASCADE and VASCADE MVP venous vascular closure systems. The CE marking allows Haemonetics to engage in the next steps of launching both products into the European Union (EU); it also allows the company to enter into other geographies that recognize CE marking. As of 2021, VASCADE MVP was the first and only FDA-approved vascular closure device indicated for use following atrial fibrillation (AF) ablation to allow same-day discharge.

In September 2023, a cross-seal, suture-mediated vascular closure device system by Terumo Medical Corporation received approval from the FDA. The device is indicated for the percutaneous delivery of sutures for closing a common femoral artery access site while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional catheterization using 8F to 18F sheaths. The Cross-Seal System is indicated for one access site per leg. Such strategic initiatives are likely to emerge as a key trend in the Europe vascular closure device market during the forecast period.

Europe Vascular Closure Device Market Overview

Cardiovascular disorders are among the most common causes of death in Germany. Changing lifestyles among the masses is a major risk factor for this disease. Cardiovascular disorders account for ~40% of deaths in Germany, followed by cancer and diabetes. According to the WHO, the death toll due to coronary heart disease in Germany reached 147,055 (i.e., 20.98% of total mortalities) in 2020. The presence of developed healthcare facilities and the increasing number of minimally invasive cardiology procedures are among the factors that are likely to create demand for vascular closure devices. According to data published in the Burden of Stroke in Europe report prepared by King's College London for the Stroke Alliance for Europe, Germany records ~88,922 stroke cases annually, which is equivalent to nearly 52 cases per 100,000 inhabitants. The total prevalence of stroke in Germany was 526,774, which accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke as it reports 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, stroke cases in Germany are likely to surge by 30% by 2035, while the prevalence of stroke is anticipated to rise to 19% by the end of 2035. Thus, the significantly growing incidence of stroke and cardiovascular disorder drives the vascular closure devices market growth in Germany.

Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)

Europe Vascular Closure Device Market Segmentation

The Europe vascular closure device market is segmented based on product type, access, procedure, end user, and country.

Based on product type, the Europe vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.

By access, the Europe vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.

By procedure, the Europe vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.

In terms of end user, the Europe vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.

Based on country, the Europe vascular closure device market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Rest of Europe dominated the Europe vascular closure device market in 2022.

Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, ENDOCOR GmbH & CO KG, Haemonetics Corp, Medtronic Plc, Teleflex Inc, and Vasorum Ltd are some of the leading companies operating in the Europe vascular closure device market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Vascular Closure Device Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Cardiovascular Diseases
    • 4.1.2 Burgeoning Demand for Minimally Invasive Devices
  • 4.2 Market Restraints
    • 4.2.1 Risk of Infection Related to Vascular Closure Devices
  • 4.3 Market Opportunities
    • 4.3.1 Untapped Potential of Emerging Economies
  • 4.4 Future Trends
    • 4.4.1 Strategic Activities by Manufacturers
  • 4.5 Impact Analysis:

5. Vascular Closure Device Market - Europe Market Analysis

  • 5.1 Europe Vascular Closure Device Market Revenue (US$ Mn), 2022 - 2030

6. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Europe Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
  • 6.3 Active Approximators
    • 6.3.1 Overview
    • 6.3.2 Active Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Active Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Passive Approximators
    • 6.4.1 Overview
    • 6.4.2 Passive Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Passive Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 External hemostatic devices
    • 6.5.1 Overview
    • 6.5.2 External hemostatic devices: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by Access

  • 7.1 Overview
  • 7.2 Europe Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
  • 7.3 Femoral Access
    • 7.3.1 Overview
    • 7.3.2 Femoral Access: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Radial Access
    • 7.4.1 Overview
    • 7.4.2 Radial Access: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by Procedure

  • 8.1 Overview
  • 8.2 Europe Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
  • 8.3 Interventional Cardiology
    • 8.3.1 Overview
    • 8.3.2 Interventional Cardiology: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Interventional Radiology
    • 8.4.1 Overview
    • 8.4.2 Interventional Radiology: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Endovascular Surgical
    • 8.5.1 Overview
    • 8.5.2 Endovascular Surgical: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by End Users

  • 9.1 Overview
  • 9.2 Europe Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgical Center
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Center: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Vascular Closure Device Market - Country Analysis

      • 10.1.1.1 Europe Vascular Closure Device Market by Country
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Germany: Europe Vascular Closure Device Market, by Product Type
        • 10.1.1.2.3.1 Germany: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 10.1.1.2.3.2 Germany: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 10.1.1.2.4 Germany: Europe Vascular Closure Device Market, by Access
        • 10.1.1.2.5 Germany: Europe Vascular Closure Device Market, by Procedure
        • 10.1.1.2.6 Germany: Europe Vascular Closure Device Market, by End Users
      • 10.1.1.3 UK
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 UK: Europe Vascular Closure Device Market, by Product Type
        • 10.1.1.3.3.1 UK: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 10.1.1.3.3.2 UK: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 10.1.1.3.4 UK: Europe Vascular Closure Device Market, by Access
        • 10.1.1.3.5 UK: Europe Vascular Closure Device Market, by Procedure
        • 10.1.1.3.6 UK: Europe Vascular Closure Device Market, by End Users
      • 10.1.1.4 France
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 France: Europe Vascular Closure Device Market, by Product Type
        • 10.1.1.4.3.1 France: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 10.1.1.4.3.2 France: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 10.1.1.4.4 France: Europe Vascular Closure Device Market, by Access
        • 10.1.1.4.5 France: Europe Vascular Closure Device Market, by Procedure
        • 10.1.1.4.6 France: Europe Vascular Closure Device Market, by End Users
      • 10.1.1.5 Italy
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Italy: Europe Vascular Closure Device Market, by Product Type
        • 10.1.1.5.3.1 Italy: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 10.1.1.5.3.2 Italy: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 10.1.1.5.4 Italy: Europe Vascular Closure Device Market, by Access
        • 10.1.1.5.5 Italy: Europe Vascular Closure Device Market, by Procedure
        • 10.1.1.5.6 Italy: Europe Vascular Closure Device Market, by End Users
      • 10.1.1.6 Spain
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 Spain: Europe Vascular Closure Device Market, by Product Type
        • 10.1.1.6.3.1 Spain: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 10.1.1.6.3.2 Spain: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 10.1.1.6.4 Spain: Europe Vascular Closure Device Market, by Access
        • 10.1.1.6.5 Spain: Europe Vascular Closure Device Market, by Procedure
        • 10.1.1.6.6 Spain: Europe Vascular Closure Device Market, by End Users
      • 10.1.1.7 Rest of Europe
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.7.3 Rest of Europe: Europe Vascular Closure Device Market, by Product Type
        • 10.1.1.7.3.1 Rest of Europe: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
        • 10.1.1.7.3.2 Rest of Europe: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
        • 10.1.1.7.4 Rest of Europe: Europe Vascular Closure Device Market, by Access
        • 10.1.1.7.5 Rest of Europe: Europe Vascular Closure Device Market, by Procedure
        • 10.1.1.7.6 Rest of Europe: Europe Vascular Closure Device Market, by End Users

11. Vascular Closure Device Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Vascular Closure Devices Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Cordis Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Vasorum Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Haemonetics Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Abbott Laboratories
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Becton Dickinson and Co
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Cardinal Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 ENDOCOR GmbH & CO KG
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Teleflex Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms